Debut Plus

112.61

+5.36 +5.00%

11 Sept 2026

BSE Listed

Sarda Proteins Ltd. (519242)

Volume: 21,972Avg Vol 1W: 46,083Avg Vol 1M: 17,27052W Range:59.95137.1
Market Cap₹101 Cr
Current Price₹112.61
Previous Close₹107.25
High / Low (52w)₹137.1 / ₹59.95
Volume21,972
Avg Vol (1W)46,083
Avg Vol (1M)17,270
Stock P/E36.21
Book Value₹10.57
Dividend Yield0%
ROE21.15%
ROA320.98%
Revenue (TTM)
Revenue Growth
Profit Margin15.28%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹3.11
P/B10.66
Debt / Equity0
50 DMA₹84.67
200 DMA₹85.65
Day change+5.00%
Price Chart
112.61 13.54% · 1Y
130631.8L
2025-09-15
2026-09-11

20-day avg volume: 19K shares

Pros
  • Healthy return on equity of 21.1%.
  • Company is almost debt-free.
  • Revenue grew 1556% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹24 Cr₹0 Cr₹11 Cr₹4 Cr₹0 Cr₹1 Cr₹13 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹2 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹6 Cr₹7 Cr₹5 Cr₹11 Cr₹11 Cr₹6 Cr₹1 Cr₹24 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-1.92-0.720.19-0.121.78-0.1911.252.96
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Equity₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 80.66% Institutions 0% Public 19.34%
Efficiency & Working Capital
ROCE20.1%
Interest Coverage0
Dividend Payout
Debtor Days0 d
Inventory Days0 d
Payable Days3 d
Cash Conversion Cycle-3 d
Working Capital Days0 d
Shareholding Details

As of 2026-06-30

Promoter80.7%
FII0%
DII0%
Institutions0%
Public19.3%
Promoter Pledge0%
No. of Shareholders2,897
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Apr 2026Jun 2026
Promoters28.4%28.4%0%0%0%0%0%0%0%0%0%80.7%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public71.6%71.6%100%100%100%100%100%100%100%100%100%19.3%
Promoter Pledge0%0%0%
No. of Shareholders3,2173,1573,1073,0473,0042,9642,9412,9382,9282,9242,9292,897
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Onix Renewable LimitedShareholding of Promoter and Promoter Group78.2%70,22,642
Divyeshkumar Mansukhlal SavaliyaShareholding of Promoter and Promoter Group1.3%1,17,200
Savaliya Piyushkumar MansukhbhaiShareholding of Promoter and Promoter Group1.1%1,00,000
Board of Directors
NameDesignationYear
Dhairya ThakkarIndependent Director2025
Namrata KarwaCompany Sec. & Compli. Officer2025
Shirish Dhirajlal SavaliyaManaging Director2025
Yagnik Arvindbhai SatasiyaChairperson & Additional Direc2025
Minal Surendra JainIndependent Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹101323
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-15Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500001111
202500001111
202500001111
Substantial Acquisitions (SAST)

12 disclosure(s)

Market03/06/2024 · 15,000
Market03/06/2024 · 15,000
Market03/06/2024 · 63,400
Market03/06/2024 · 10,000
Market24/05/2024 · 1,24,691
Market24/05/2024 · 15,000
Company Information
Incorporated1991
ChairmanYagnik Arvindbhai Satasiya
AuditorS K Agarwal & Associates/S D Mehta & Co
Investor Email[email protected]
🌐 www.sardaproteins.com

📍 2nd Flr 2 Sai Collection bldg, Bus Stand Rd Police Control Rm, Alwar, Rajasthan, 301001

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search